Spread and Control of Prion Diseases in the Food and Feed Chains by Rao, Qinchun & Peggy Hsieh, Yun-Hwa
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 9
Spread and Control of Prion Diseases
in the Food and Feed Chains
Qinchun Rao and Yun-Hwa Peggy Hsieh
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/62118
Abstract
Prion diseases, or transmissible spongiform encephalopathies (TSEs), are a group of
chronic, progressive, and fatal neurodegenerative disorders that affect a variety of mam‐
malian species. This chapter discusses the issues raised by two foodborne prion diseases,
namely bovine spongiform encephalopathy (BSE) and variant Creutzfeldt–Jakob disease
(vCJD), particularly those related to their spread in cattle and humans, the contamination
of specified risk material (SRM) in meat, the relevant regulations, and appropriate detec‐
tion methods for surveillance.
Keywords: Bovine spongiform encephalopathy, variant Creutzfeldt–Jakob disease, speci‐
fied risk material, central nervous system tissues, regulations, detection methods
1. Introduction
Prion diseases or transmissible spongiform encephalopathies (TSEs) are a group of chronic,
progressive, and fatal neurodegenerative disorders that affect a variety of mammalian species.
They include scrapie in sheep and goats, chronic wasting disease in deer and elk, bovine
spongiform encephalopathy (BSE or so-called “mad cow disease”) in cattle, and variant
Creutzfeldt–Jakob disease (vCJD) in humans.[1] Since the term “prion” was coined by Dr.
Stanley Prusiner in 1982,[2] the extensive research on prion diseases has investigated their
molecular biology,[3] causes,[4] pathogenesis,[5] genetics,[6] types,[7] biochemical mecha‐
nisms,[8] and therapies,[9] among other aspects. A prion is a proteinaceous infectious particle
that lacks nucleic acid.[7] Abnormal prions (PrPSc) are the pathologic isoforms of prions and
are expressed in specified risk material (SRM) such as bovine central nervous system (CNS)
tissue.[10] PrPSc has a high β-sheet content, is extremely resistant to heat and proteases, and is
insoluble in non-denaturing detergents.[11, 12] Infection of prion diseases occurs naturally via
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the oral route as well as by blood transfusion and maternal routes.[13] This chapter reviews
the research into two foodborne prion diseases, BSE and vCJD, related to their spread in cattle
and humans, the contamination of SRM in meat, the relevant regulations, and the detection
methods available for surveillance.
2. Spread of BSE and vCJD
Research into clinical BSE cases has reported that 84.3% of the BSE infectivity is associated with
bovine CNS tissue.[14] Another study found that the CNS tissue carries 89.7% of the infectivity.
[15] With regard to the pathogenesis of BSE, animal by-products such as meat and bone meal
(MBM), which have been used as nutritional supplements in livestock feedstuffs for more than
100 years, are major carriers of the infectious agent PrPSc.[16, 17] Significant changes in the
manufacturing processes of feedstuffs that took place in the 1970s, including the introduction
of mechanical systems that permitted continuous flow production and solvent extraction of
fats, enabled PrPSc to enter the livestock feed chain.[18, 19] The recycling of animal by-products
from BSE-infected animals caused a wide spread infection of BSE in cattle,[19] subsequently
affecting the food chain through the consumption of the PrPSc-contaminated meat products.
[20] To date, more than 190,000 BSE cases have been reported in 28 countries since it was first
identified in the UK in around 1986,[21] with approximately 97% of the cases being reported
in the UK (Figure 1).[22] It has been estimated that the total number of BSE-infected cattle is
around one million, of which around 75% entered the human food chain during the 1980s and
early to mid-1990s.[23, 24] BSE has had a huge impact on the beef industry worldwide.[25-30]
In the USA, estimates of the total loss of beef and offal exports ranged from $3.2 billion to $4.7
billion in 2004 after the nation’s first BSE case was confirmed at the end of 2003.[31] Although
the link between BSE and vCJD through eating prion-contaminated meat has not been
conclusively proven, the consumption of food of bovine origin contaminated with PrPSc has
been strongly linked to the occurrence of vCJD in humans.[20] Both vCJD and BSE share the
same infectious agent, PrPSc.[32, 33] A total of 229 vCJD patients have been identified in 12
countries since it was first discovered in the UK in 1996 (Figure 1),[34, 35] of whom about 77%
were in the UK (Figure 1).[36] It should be noted that following the successful containment of
the BSE epidemic through the imposition of strict feed controls for ruminant animals, the
numbers of cases of both BSE and vCJD in the UK have declined significantly since 1992 and
2000, respectively (Figure 1).
3. Contamination of SRM in meat products
During the animal slaughter process, two major SRM, brain and spinal cord material, can easily
contaminate meat products.[37-40] In general, there are four main pathways for the contami‐
nation of CNS-based SRM in meat products, which can occur at any stage during these
processes: animal stunning, animal pithing, carcass dressing, and advanced meat recovery.
The risks associated with each process have been studied and are discussed in turn below in
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the following sections. The major results of the relevant studies for each of these four pathways
are summarized in Table 1.
3.1. Animal stunning
The stunning method has been widely used in many countries and areas of the world for some
time as it slaughters the animals humanely. Stunning renders the livestock unconscious before
slaughter, but because the heart of the stunned animal continues pumping for several minutes
after stunning, during this time any CNS tissue that enters the jugular venous blood could still
be spread throughout the body, contaminating both muscle and bone marrow via the blood
circulation.[41] Several CNS markers that have a molecular weight similar to the PrPSc (MW:
30 kDa),[3] including syntaxin 1B and glial fibrillary acidic protein (GFAP),[42, 43] have been
detected in non-CNS tissue after stunning. It thus seems likely that PrPSc could also be present
in the edible carcass after stunning. Two types of captive bolt stunner, penetrative and non-
penetrative, are widely used to stun domestic animals prior to bleeding (Figure 2). Most
abattoirs prefer to use penetrative captive bolt stunners, either with or without air injection,
to render cattle quickly and painlessly unconscious before slaughter.
Figure 1. Number of reported BSE-cases (blue) and number of reported vCJD-cases (red) in the UK (1987-present)[22, 36]
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Routes by which meat becomes 
contaminated by SRM 
Location of SRM SRM-
contaminated
samples (%) 
Species Detection methods References 
Cattle Sheep Microscopy Macroscopy Immunoassay 
ELISAa IBb IHCc ICHd 
Animal 
stunning 
Penetrative stunning 
with air injection 
Left and right branches of 
the main pulmonary artery 
2.5–5 √   √     [46] 
Right ventricle 33 (nh=1050) √   √     [51] 
Jugular vein 26.7 (n=15) √  √  Syntaxin 1-B 
Annexin V 
  S100β [48] 
Jugular vein 13.3 (n=15)  √ √  Syntaxin 1-B   S100β [49] 
Aorta 18.2 (n=11)  √      NFe S100 [47] 
Heart, lung, liver and 
kidney 
    √     [52] 
Penetrative 
stunning 
without air 
injection 
 
Pneumatic
-powered 
stunning 
 
Heart 12 (n=450) √   √     [51] 
Cartridge-
operated 
stunning 
Heart 1 (n=480) √   √     [51] 
Jugular vein 13.3 (n=15)  √      S100β [49] 
Pulmonary artery and right 
ventricle 
8.5 (n=412)    √     [56] 
Jugular vein 4 (n=100) √  √  GFAPf   S100 [55] 
  Jugular vein 1 (n=360) √    GFAP    [178] 
  Carcass surface 100 (n=30) √    GFAP    [43] 
Non-penetrative 
stunning 
Jugular vein 2 (n=100) √  √  GFAP   S100 [55] 
  Carcass surface 83.3 (n=30) √    GFAP    [43] 
Animal pithing Jugular vein 6.3 (n=16) √  √  Syntaxin 1-B 
Annexin V 
  S100β [48] 
Pulmonary artery and right 
ventricle 
4.1 (n=314)    √     [56] 
Carcass dressing Hand-held screen, tray, 
apron, and internal surfaces 
of the carcass along the cut 
vertebral surface 
 √    S100β    [69] 
 Sawing water, areas of 
thoracal and cervical 
regions of the carcass 
 √     NSEg   [56] 
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Routes by which meat becomes 
contaminated by SRM 
Location of SRM SRM-
contaminated
samples (%) 
Species Detection methods References 
Cattle Sheep Microscopy Macroscopy Immunoassay 
ELISAa IBb IHCc ICHd 
 Captive bolt, floor of the 
receiving platform, aprons, 
hands, knives, captive bolt 
aperture, head wash water, 
spinal cord channel, saw, 
table striploin, conveyor 
belt, and beef hide 
 √    Syntaxin 1B 
GFAP 
   [42] 
 Captive bolt gun/hole, 
apron, hands, saw, spinal 
cord channel, and meat 
 √    Syntaxin 1B 
GFAP 
   [67] 
 Carcasses, loin, forerib, 
minced meat, worktable 
surface, saw, and air 
samples 
 √    S100β 
GFAP 
   [179] 
 Split vertebral face and saw  √    GFAP    [69] 
AMRSi Meat 35 √        [77] 
 Meat 41.2 (n=17) √      NF 
Synapto
physin 
GFAP 
 [75] 
 Meat  17.2 (n=279) √      GFAP  [76] 
aELISA, enzyme-linked immunosorbent assay; bIB, immunoblotting; cIHC, immunohistochemistry; dICH, immunocytochemistry; eNF, neurofilament; fGFAP, glial fibrillary acidic protein; gNSE, neuron-specific enolase;
h
n, sample size; iAMRS, advanced meat recovery system. 
Note: NF is heteropolymer intermediate filaments that are composed of three neurofilament subunits (NF-L, NF-M and NF-H), which are expressed mainly in neurons.[180] 
S100 protein (MW: 10.5 kDa) is a calcium-binding protein found predominantly in the vertebrate nervous system.[181] Syntaxin 1B (MW: 33 kDa) which is an integral membrane protein exclusively and abundantly 
expressed in nervous tissues.[182] 
Table 1. Summary of the results of SRM contamination through the four major routes during animal slaughtering and
meat processing
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Stunning
Penetrative
With air 
injection
Without air 
injection
Pneumatic-
powered
Cartridge-
operated
Other
Non-
penetrative
Cartridge-
operated
Electrical
Other
Figure 2. Classification of animal stunning techniques
3.1.1. Penetrative stunning with air injection
This stunning technique involves the injection of compressed air into the cranium of cattle to
effectively disrupt the brain structure. In 2001, it was estimated that 15% of cattle were stunned
using an air-injection stunner in the USA.[44] However, penetrative stunning with air injection
poses a major risk of spreading the PrPSc from the BSE-infected CNS tissue to the edible carcass.
Similarly, it is well known that severe penetrating injuries to the human brain, such as a
gunshot wound, can cause acute brain damage and produce cerebral emboli that end up in
the lung.[45]
For each BSE-infected animal stunned with this type of stunner, there is a 31.2, 16.3, 3.3, and
0.7% probability that a portion of the PrPSc would be transferred to the blood, heart, lung, and
liver, respectively,[44] which is significant because it has been estimated that 60% of the liver,
50% of the heart, 25% of the kidney, and 5% of the blood are potentially available for human
consumption.[44] Studies have also found that an air-injection stunner forced visible pieces of
CNS tissue into the circulatory system of stunned cattle and sheep.[46, 47] This device has been
shown to cause the formation of grossly visible brain tissue in the left and right branches of
the main pulmonary artery in 2.5–5% of cattle,[46] in the jugular venous blood of cattle and
sheep,[48-50] and in the aortic blood from sheep.[47] Particles of brain tissue as large as 20 µm
in diameter can pass through the ovine pulmonary capillary network and enter the systemic
arterial circulation during stunning, suggesting that this technique could easily disperse
PrPSc throughout the edible carcass.[47] It has also been reported that CNS tissue has been
observed in 33% of cattle hearts,[51] and in the kidneys of cattle stunned with air-injection
stunners.[52]
Another factor to consider is that on occasion when operation of air-injection stunners fails,
leading to an increase of CNS emboli formation and deposition, the probability of PrPSc transfer
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could be nearly 50% higher in blood, twice as high for the heart, and 10 times higher for the
lung and liver.[44] Furthermore, a slaughterer who uses this type of stunner for too long or
uses it successively to immobilize the same cattle could significantly increase the CNS tissue
dispersion in blood vessels of the carcass.[51] It is also common for this type of stunner to press
brain material out of the brain cavity through the bolt hole in the animal skull and splash onto
the operator’s face.[41, 53] Based on these results, the use of this type of stunner has been
prohibited in many BSE-reporting countries and areas.
3.1.2. Penetrative stunning without air injection
This type of captive bolt stunner has a sharp-rimmed steel bolt and is powered by either
compressed air (pneumatic-powered) or a blank cartridge that produces sufficient penetration
force to initiate trauma to the cortex. It is the preferred tool for stunning cattle in the EU; 79
and 96% of the slaughterhouses in Europe use this method for cattle and calves, respectively.
[54] However, the use of pneumatic-powered stunners and cartridge-fired stunners produced
visible CNS clots in 12 and 1% of the cattle heart samples, respectively.[51] In addition, after
using this type of stunner, CNS tissue was detected in the jugular venous blood from sheep,
[49, 50] in venous blood from cattle,[55] in bovine pulmonary arterial system,[56] and on the
surface of beef carcasses.[43]
In a study designed to trace the spread of CNS tissue in the cattle body after stunning with a
cartridge-fired stunner, a marker microorganism, Pseudomonas fluorescens, was inoculated into
the bovine brain via the stunning procedure.[57] The researchers reported finding this
bacterium in the animal’s blood, spleen, liver, kidney, lymph node, lung, and spinal cord.
Using a similar approach, two microorganisms, Escherichia coli and P. fluorescens, have been
detected in the blood, liver, lung, spleen, lymph node, longissimus muscle, and on the carcass
surface of stunned sheep.[58] These studies demonstrate that the use of penetrative stunning
without air injection could still spread CNS tissue throughout other portions of the carcass.
As with air-injection stunning, multiple use of this type of stunner also poses a high risk of
spreading PrPSc from the infected brain to the edible carcass. In 2004, as few as 71% of slaugh‐
terhouses in the USA using penetrating captive bolt stunning successfully stunned 99–100%
of the cattle with one shot and only 50% of abattoirs in Canada achieved the same target.[59]
In 2005, this percentage decreased to 55% in US beef plants.[60] Since then, the percentage has
increased gradually in both countries, reaching 91% in the USA by 2011.[61] In the EU, about
4–6.6% of captive bolt stunning in cattle requires a second stun.[54] Such practices could
increase the risk of CNS tissue contamination in meat products. Although this type of stunner
exerts less impulsive force on the stunned animal compared with air-injection stunners, it
remains a threat to meat safety because this type of stunner is still in use worldwide.
3.1.3. Non-penetrative stunning
Non-penetrative stunning devices include the non-penetrating cartridge-operated stunner
and the electrical stunner. Several studies have reported that no CNS tissue was detected in
either aortic or venous blood samples collected from cattle or sheep after using these two
devices.[48-50] However, other studies have detected brain tissue in venous blood samples
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from stunned cattle,[55] and on the surface of beef carcasses[43] after non-penetrating
stunning. There also is an increased risk to operators as some animals may be inadequately
stunned with non-penetrating stunning and recover their consciousness during slaughtering.
Electrical stunning is the main alternative method for stunning cattle, but it is expensive to
install and meat quality defects such as petechial hemorrhages have been linked to electrical
stunning in sheep.[62]
3.2. Animal pithing
Pithing is the insertion of an elongated rod-shaped instrument into the cranial cavity of a
stunned animal to further lacerate the CNS tissue.[63, 64] This operation prevents the animal
stunned by a penetrating captive bolt from recovering permanently.[52] Pithing is considered
by the industry to be a more effective technique for maintaining the safety of the operator and
was used in 70% of UK abattoirs as recently as 1997.[50] However, in 2001, this technique,
which has never been used in the USA,[52] was banned in the EU.[65] Brain tissue has been
detected in venous blood[48, 50] and arterial blood samples[56] from cattle after pithing.
Based on scientific evidence of the dispersion of CNS-based SRM in response to various
stunning and pithing techniques, the EU has ranked the stunning methods used in ruminants,
from the most hazardous to the least dangerous, as: (1) penetrative stunning with air injection;
(2) penetrative stunning without air injection; (3) captive bolt stunner with pithing; (4) captive
bolt stunner without pithing and free bullet; (5) non-penetrative stunner and electro-narcosis.
[66] Two techniques, air-injection stunning and pithing are now prohibited worldwide.
However, there is still a 50% probability that emboli will be deposited in the blood of an animal
stunned with a non-air-injection stunner.[44]
3.3. Carcass dressing
During animal slaughtering, the general sequence followed during the dressing procedure is
stunning followed by exsanguination, dehiding, evisceration, splitting, washing, and chilling.
[42] Of these steps, stunning is not the only point at which the carcass can potentially be
contaminated with CNS tissue; other steps in the slaughtering procedure also have a high
probability of dispersing CNS-based SRM across the carcass (Table 1). CNS tissue has been
found in samples collected at a number of points along the slaughter line, including on the
captive bolt gun, on the aprons worn by the operators, on their hands and the saws used, and
in the longissimus muscle.[67]
In a study tracking two marker microorganisms, E. coli and P. fluorescens, both bacteria were
transferred from the first stunned sheep to the stun wounds of the next 10 sheep stunned using
the same contaminated penetrative cartridge-operated pistol.[58] These bacteria were also
detected in the sheep’s blood and on their carcass surfaces.[58] Perhaps most worryingly, the
marker organisms were found in the air, and on the hands and aprons of the operator.[58] In
another similar study,[57] the marker organism P. fluorescens was detected in the slaughter
environment immediately after stunning and at each subsequent stage of the slaughter-
dressing process, including on the hands of the operators, the slaughter equipment (captive
bolt gun and knife), the cattle hide, and the carcass splitting saw.
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Spinal cord material is easily spread to bovine carcasses during carcass splitting. The majority
of the CNS contamination was found on the internal surfaces of the carcass and along the cut
vertebral surface, with lesser levels of contamination inside the body cavity.[68] CNS tissue
was also detected in the surroundings during splitting, including on the hand held screen, the
tray and apron, the captive bolt, the captive bolt aperture, and the floor of the receiving
platform.[42, 69] Spinal cord tissue can also be transferred to subsequent bovine carcasses
during carcass splitting. The main risk of subsequent carcass contamination comes from the
splitting saw.[68] Overall, these studies demonstrate that the practice of carcass dressing,
especially splitting, can lead to the extensive spread of SRM within the abattoir environment,
contaminating equipment, surfaces, operators, and edible carcasses. There are also grounds
for concern regarding operator safety when dealing with CNS tissue, particularly due to the
aerosol of cerebrospinal fluid and spinal cord produced during the splitting process.
3.4. Advanced meat recovery
Mechanical systems have been developed to separate meat from bone by scraping, shaving,
or pressing the meat from the bone, for example, via advanced meat recovery systems (AMRS).
AMRS enables processors to remove any remaining muscle tissue from beef carcasses without
breaking the bones.[70] About 70% of fed cattle and hogs, and 60% of cows slaughtered in the
USA were processed using AMRS in 1998[71] and around 5,000 metric tons of mechanically
recovered meat (MRM) were produced yearly during the period 1980–95 in the UK.[72]
Although AMRS makes deboning more efficient and considerably faster than using a knife, if
spinal cord material is attached to the spinal column as it enters these machines, it can be
incorporated into the meat product produced.
A number of studies have detected CNS tissue in MRM products (Table 1).[73-76] In 2002,
about 35% of US bovine MRM contained CNS tissue[77] and other studies detected spinal cord
tissue in 29%[77] and 33.3%[75] of bovine MRM samples. Dorsal root ganglia tissue was found
in 10% of the MRM samples.[77] Schmidt et al.[74] reported that 50% of the bovine MRM
samples from 14 slaughter plants that they tested were positive for CNS protein. In a later
study by the same group,[76] 17.2% of the MRM samples tested were contaminated by CNS
tissue.
By the 1990s, about 90% of the beef MRM produced was being used in burgers in the UK.[78]
Around 75–80% of individuals surveyed in France consumed MRM products from burgers,
and the consumption of burgers increased by 40% over the period 1980–1995.[79] Frequent
consumption of beef and beef products, including burgers and meat pies, containing the MRM
or head meat has been linked to an increased risk for vCJD;[80] infection with vCJD is thought
to be predominantly due to exposure to BSE in beef MRM and head meat products.[81]
Looking at the results of the present review (Table 1), every stunning method except for
electrical stunning could potentially contaminate meat products by dispersing CNS-based
SRM, including any PrPSc present in sub-clinically infected cattle. Although the use of air-
injection stunning, pithing, and AMRS has now been prohibited during animal slaughtering
and meat processing (Table 2), penetrative stunning without air-injection and non-penetrative
stunning are still in widespread legal use. Slaughter conditions and procedures such as carcass
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dressing, especially the splitting process, can also result in widespread contamination within
abattoirs, contaminating equipment, surfaces, operators, and carcasses destined for human
consumption. CNS contamination of bovine carcasses simply cannot be eliminated by the
slaughtering technology currently used.
4. The regulation of SRM
The contamination of animal carcass by SRM is not only a food and feed safety issue, but also
of global economic importance, leading countries or areas such as the UK, the EU, Japan,
Canada, and the USA to institute strict regulations to prevent SRM entering the human food/
animal feed chain (Table 2). Although SRM has different definitions in different countries and
areas, bovine CNS tissue (brain and spinal cord) tops every list of prohibitive materials due to
its high prion infectivity.
Prohibited
activity
UK EU Japan USA Canada
Air-injection
stunning
April 1, 2001 April 1, 2001 N/A* January 12, 2004 July 24, 2003
Pithing April 1, 2001 January 1, 2001 N/A Never be used July 24, 2003
AMRS December 15, 1995 October 1, 2000 N/A January 12, 2004 July 24, 2003
SRM in food December 17, 1997 January 1, 1998 July 4, 2002 January 12, 2004 August 23, 2003
SRM in feed January 1, 1998 January 1, 2001 October 2001 April 27, 2009 July 12, 2007
* N/A, not available
Table 2. Legislation related to prion disease control
Given that it was the first and most seriously area affected, it is not surprising that the early
legislation to control the spread of prion diseases came from the UK. In 1995, the UK banned
the use of MRM from bovine vertebral column for human consumption[82] and in 1996, the
“over thirty months” rule came into force, which automatically banned older cattle from
entering the human food chain.[83] In 1997, the UK enacted a comprehensive set of SRM
regulations,[84] which classified SRM into specified sheep or goat material and specified
bovine material. It also emphasized that no person should use or sell any SRM, or any food
containing SRM, for human consumption. To further prevent SRM from entering the human
food chain, the UK prohibited the practice of pithing in 2001.[85] The EU was also quick to
take action; since the consumption of BSE-infected feedstuffs by ruminants was rapidly
identified to be the main BSE transmission channel, in 1994 the EU banned the use of proteins
originating from mammalian tissues for feeding ruminants.[86] Largely as a result of this feed
ban, the UK’s BSE risk status dropped from high to low between 1996 and 2012. Since 2013,
the regulations have been relaxed somewhat and cattle aged over 72 months (O72M) are now
permitted to enter the food chain if they have tested negative for BSE.[87]
Significance, Prevention and Control of Food Related Diseases250
In 2001, the World Health Organization recommended that all countries should introduce risk
management procedures such as the identification and removal of entire bovine heads and/or
prohibiting the harvesting of all MRM. All tissues that have been shown to be capable of
carrying BSE infectivity should be removed and destroyed. If the risk is high, additional
precautions should be taken such as prohibiting cattle over a certain age from entering the
food chain.[88] The World Organization for Animal Health suggests that when countries
import beef products from a BSE risk country or area, meat processing should not use air-
injection stunning or pithing.[89]
In the EU, the use of air-injection stunning has been banned for slaughtering cattle since 2001;
[90] it has also prohibited pithing since 2001.[65] In 1997, the EU enacted strict regulations
prohibiting the use of SRM,[91] including the skull, brain, eyes, tonsils and spinal cord of cattle,
sheep, and goats aged over 12 months and the spleens of sheep and goats. This was later
extended to include bovine intestines in 2000[92] and vertebral columns in 2001.[93] Since 2000,
all the member states of the EU, including the UK, are prohibited from producing MRM from
bones of the head and vertebral columns of bovine, ovine, and caprine animals,[65] and this
was extended to include all types of bones from these three species in 2001.[93] From 2001
onwards, SRM was excluded from the feed chain as a result of an EU-wide ban on the feeding
of processed animal protein to all farmed animals.[94] In 2013, BSE testing in the EU has been
changed to the O72M rule.[87]
Among the Asian countries, Japan has been the most severely affected by TSE, with about 36
cases of BSE and one case of vCJD being confirmed since 2001.[21, 95] In 2002, Japan announced
that bovine MBM could not be used as an ingredient in animal feedstuffs and prohibited the
use of specified materials from cattle.[96] However, the bovine vertebral column can still be
consumed as food if it is derived from cattle originating from a BSE-free country or zone.[97]
Because the BSE risk status has moderated somewhat, the age of cattle subject to inspection
for BSE in Japan was revised upward from zero months to 21 months in 2005.[98] In 2013, it
was further revised and is now only required for cattle over 48 months of age.[99]
In Canada, the first cases of BSE and vCJD were reported in 2003 and 2002, respectively,
triggering a food directorate policy on SRM in the food supply that was implemented in 2003.
[100] This required the removal of SRM from all cattle during the slaughtering process and
prohibited its sale or import for human consumption.[101] The vertebral column from all cattle
aged 30 months or older must now be removed as an inedible product and cannot be used in
the preparation of MRM.[102] Canada has also prohibited the use of air-injection stunning and
the pithing technique for cattle.[102]
The USA banned the use of proteins originating from ruminant tissues for feeding ruminants
in 1997.[103] Later, the USA issued a prohibition of SRM consumption as food in January 2004,
adopting a definition for SRM that is similar to that used in Canada.[104, 105] To ensure that
AMRS do not become a means of spreading CNS tissue into meat products, the USA has also
prohibited the use of brain, spinal cord, dorsal root ganglia, trigeminal ganglia, and significant
amounts of bone solids or marrow of all cattle, as well as the skull and vertebral column of
cattle 30 months of age and older, in AMRS.[106] The National Animal Identification System,
an efficient and effective animal identification program, has been implemented in the USA
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since 2004 to support animal disease monitoring, surveillance, and eradication programs.[107]
The USA has also prohibited the use of a number of cattle materials, including CNS-based
SRM, in animal feedstuffs since 2009.[108] The USA currently prohibits the slaughter of cattle
that are unable to stand or walk ("downer" cattle) when presented for pre-slaughter inspec‐
tion[109] and in January 2004 also banned air-injection stunning of cattle; pithing has never
been used.[52] From January 2004 to May 2005, the USDA performed inspection and verifica‐
tion procedures in about 6,000 meat and poultry establishments and found 1,036 procedures
(< 1%) that were not in compliance with the regulations related to SRM.[110] In 2008, about
1.5% of the US companies handling materials prohibited from use in ruminant feed (n=7,876)
committed technical violations, mostly consisting of minor recordkeeping lapses or conditions
involving non-ruminant feeds.[111] However, in January 2006, Japan suspended all US beef
imports after discovering SRM in beef products exported from the USA.[112] In South Korea,
US beef imports did not resume until June 26, 2008, after having been suspended in 2003 after
the first BSE case was reported in the USA.[113]
Based on statistical information related to MBM,[114] it is clear that the problems with SRM-
contaminated feed should not be forgotten. In 2000, the total amount of mammalian MBM
produced in the USA was about three million metric tons.[115, 116] Ruminant tissues have
been prohibited in ruminant feed in the USA to prevent the spread of BSE since 1997[103] and
about 41,520 metric tons of animal feed in the USA were recalled between 2006 and 2007 due
to the omission of the cautionary BSE statement on the label or as a result of ruminant MBM
contamination during the feed processing procedure.[117] As the data shown in Table 1, it is
very easy for meat products to become contaminated by bovine CNS-based SRM when the
animal is slaughtered and during meat processing. In 2012, about 53% of the red meat produced
in the USA. was beef,[118] but fewer than 1.2% of the cattle slaughtered are tested for BSE each
year.[119, 120] As part of the regulation enforcement, about 65,693 metric tons of ruminant
SRM-contaminated cattle products in the USA have been recalled since 2003.[121]
5. Detection methods for surveillance of prion diseases
As international trade continues to increase, in order to successfully enforce food and feed
safety regulations and avoid economic loss, many nonclinical methods for the detection of the
contaminated products have been developed. Overall, these detection methods can be
classified into two types: non-immunochemical detection (i.e., chromatography, spectroscopy,
and polymerase chain reaction (PCR)) and immunochemical detection methods.
Among the non-immunochemical detection methods, chromatography is typically used to
separate molecules based on differential absorption and elution, which involves the flow of a
fluid carrier over an immobile absorbing phase. Using chromatography, brain-specific fatty
acids such as lignoceric acid and the cis/trans isomers of nervonic acid[122, 123] had been used
as the analyte for the detection of the presence of CNS tissue in meat products through their
characteristic component patterns. Spectroscopic techniques are based on the unique absorb‐
ance profiles of the sample components at specific wavelengths of the electromagnetic spectrum.
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Near-infrared spectroscopy[124] and attenuated total reflectance Fourier transform infrared
spectroscopy[125] have both been used to analyze bovine spinal cord in ground beef. Some CNS
fatty acids have also been used as markers in gas chromatography–mass spectrometry (GC–
MS).[126, 127] However, these methods require expensive instruments and reagents and highly
trained staff; their sophisticated nature and the laborious sample preparation involved have
limited the utility of these instrumental methods for routine analysis. Alternatively, its ability
to detect GFAP mRNA makes PCR a sensitive technique for the detection of bovine CNS tissue
in meat products.[128-130] However, although PCR can achieve a very low detection limit, it
suffers from serious drawbacks,  once again requiring expensive instrumentation and re‐
agents and expert technicians. PCR methods are also prone to contamination.[130-132]
Immunochemical detection methods based on the specific immunoreactions between an
antibody and its target antigen have been extensively employed for the detection of CNS
contamination in meat (Table 1), generally in the form of an enzyme-linked immunosorbent
assay (ELISA),[76, 128, 133-143] immunoblotting[137-140, 144-149] or immunohistochemistry.
[145, 146, 150-152] There are a number of advantages associated with using an immunoassay.
For example, no serious instrumentation is required; it is easy to operate and it employs
minimal reagents. In the case of ELISA, it not only has a large-scale screening and field test
capability, but is also a rapid, specific, and sensitive technique. Several markers have been
explored to detect bovine CNS tissue in meat products with immunoassays, either using
monoclonal (mAb) or polyclonal (pAb) antibodies.
5.1. CNS markers for non-immunochemical detection methods
5.1.1. Cholesterol
Cholesterol (MW: 386.7 g/mol) is a sterol component of cell membranes, hormones, and bile
acids. It has been reported that 85 g of brain tissue may contain as much as 2,640 mg of
cholesterol, while the same amount of a meat sample will only contain up to 85 mg cholesterol.
[153] Although cholesterol is not specific to CNS, it can serve as a useful marker for a screening
test due to the low-cost and rapid procedures available for measuring it. Lucker et al.[146]
pioneered the use of cholesterol to analyze CNS tissue in meat products, using it to detect the
cholesterol content of 402 heat-treated meat products from different food markets in Germany.
Sixteen field samples (4%) were identified as being possibly contaminated with CNS tissue
using this procedure, but the presence of CNS tissue was confirmed by immunoblotting for
both neuron-specific enolase (NSE) and GFAP in just 7 of these 16 meat products. This suggests
that cholesterol is not a reliable marker for CNS tissue due to its non-tissue specificity. It can,
however, be used to roughly screen for CNS residue in meat products even though the accuracy
is much lower than that of markers such as GFAP and NSE.
5.1.2. Nervonic acid
Nervonic acid (15-tetracosenoic acid, MW: 366.6 g/mol), a monounsaturated long chain fatty
acid (C 24:1), is enriched in nervous tissue and is mainly present in the sphingolipids of the
brain. As it is seldom found in non-CNS tissue, nervonic acid has been used as a marker
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indicating the presence of CNS for the detection of SRM in meat products by chromatographic
techniques. Based on the different ratios of cis/trans isomers of nervonic acid in different animal
species, nervonic acid has also been used to differentiate CNS tissue from various animal
species in meat products using an on-line liquid chromatography–gas chromatography (LC–
GC) method developed by Barcarolo et al.[123] The authors reported that the ratio of the cis/
trans isomers can be used to provide a rough estimate of the age of the animal but may not be
an accurate method for the detection of CNS adulterant. Biedermann et al.[154] analyzed the
concentrations of fatty acids typical in bovine CNS, including docosahexaenoic acid (C22:6),
lignoceric acid (C24), nervonic acid, and cerebronic acid (C24OH), using GC–MS to determine
the CNS content The detection limit for CNS using this GC–MS method was 0.01%. In 2003,
Agazzi et al.[122] reported an enhanced GC method for the detection of isomers of nervonic
acid in meat products, reporting that the ratio of the cis/trans isomers of nervonic acid not only
exhibit species specificity but also show a significant difference between cow and calf, and
between pig and piglet.
Biedermann et al.[127] went on to study the structural characterization of nervonic acid as a
marker for SRM using GC–MS and found that the ratio of cis/trans isomers used previously
should be replaced by the ratio of positional isomers, i.e., the ratio of ω9/ω7-nervonic acid (15c-
C24:1/17c-C24:1). Overall, although nervonic acid may be a specific and stable marker, the GC–
MS-based CNS method is costly, requires a lengthy analysis time, and the data interpretation
is highly complex. In addition, the lack of species and age specificity of nervonic acid for the
detection of CNS disqualifies the GC–MS-based method as an effective method.
5.1.3. Glial Fibrillary Acidic Protein (GFAP) mRNA
In the CNS, GFAP (MW: about 50 kDa) is the major component of the filaments found in the
astrocytes that support the functions of nerve cells.[155] In the peripheral nervous system
(PNS), GFAP is mainly expressed by Schwann cells. The PCR method has been used in several
studies to detect GFAP mRNA as a potential marker of CNS tissue contamination in meat
products.
Seyboldt et al.[130] developed a reverse transcription-PCR (RT-PCR) assay coupled with
restriction fragment length polymorphism for the detection of GFAP mRNA from bovine CNS
tissue. Although this approach suffered from cross-reactions with unheated heart and skeletal
muscle tissues, heat treatment (70 °C for 20 min) prior to RNA extraction was found to reduce
the cross-reaction with a detection limit of 0.5% (g/g) heated bovine brain in bovine minced
meat. In another study[143], a similar method was able to detect 0.25% (g/g) bovine CNS tissue
in pork liver sausage (after a heat treatment of 80 °C for 80 min) that had been stored up to 28
days at 4 °C, although native peripheral nerves showed positive results.
Abdulmawjood and co-workers[129, 131, 156] developed a quantitative real-time RT-PCR to
detect GFAP mRNA. Their system was capable of detecting down to 0.1% of CNS tissue in
strongly heated (120 °C for 15 min) or medium-heated (80 °C for 90 min) meat samples (50%
pork and 50% beef), and 0.2% of CNS tissue in pork liver sausages (80 °C for 1 h). However,
low levels of GFAP could still be detected in peripheral nerves (sciatic and axillary nerves) and
non-neuronal tissues (parotid gland, pancreas and adrenal gland).
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5.2. CNS Markers for immunochemical detection
5.2.1. GFAP
The immunochemical differences between CNS-GFAP and PNS-GFAP are well known [157],
and GFAP was first exploited to indicate the presence of brain or spinal cord tissues in meat
as early as 1999 [134]. It has since been utilized as a marker for the detection of CNS tissue in
meat products in a number of immunoassay systems [74, 76, 133, 141, 158]. Schmidt et al. were
the first to develop a colorimetric sandwich ELISA in 1999 [134] and went on to develop an
improved fluorescent sandwich ELISA in 2001 [135]. Although this fluorescent method was
capable of detecting the presence of as little as 0.05% (g/g) bovine brain and spinal cord in beef,
once again this assay suffers from a cross-reaction with PNS-GFAP, which is present in sciatic
nerve and cervical ganglion tissue and is not considered an SRM [135]. These results suggest
that the anti-GFAP pAb used in their assay was not actually specific to the CNS tissue.
GFAP has also been used as a CNS marker in a number of immunoblotting techniques [137,
145-147]. In a study by Lucker et al. [146], the immunoresponse of heat-treated samples was
reduced significantly, however, and the sensitivity of the assay was inadequate when inten‐
sively heat-treated meat products were analyzed. Several other studies have also shown that
the ability to detect GFAP is diminished when meat samples are subjected to severe heat
treatment [133, 135].
5.2.2. Neuron-Specific Enolase (NSE)
NSE (MW: 48 kDa) is an enzyme that is found in both neurons and neuroendocrine cells. The
immunological CNS specificity of γγ-enolase has been used in clinical research for a long time
[159], and in 1999 Lucker et al. were the first to adapt this clinical method to permit the use of
NSE as a marker for the detection of CNS tissue in meat products using immunoblotting [148].
The detection limit of this assay was 1% (g/g) spiked brain in cooked (100 °C for 1 h) sausages
of the emulsion type. They suggested that the sensitivity of the assay could be dramatically
improved by removing the sample’s fat content (30 to 40%) using Soxhlet extraction, although
this is exceptionally time-consuming, requiring 8 h to extract the fat.
Several commercial immunochemical test kits have been developed [160]. Hughson et al. [140]
compared the performance of two commercial kits, the RIDASCREEN GFAP kit and the
Brainostic NSE kit (Table 3), for the detection of CNS tissue in meat products; these kits were
based on the methods proposed by Schmidt et al. [134] and Lucker et al. [148], respectively.
Hughson et al. [140] reported that levels down to 0.1% (g/g) of ovine spinal cord tissues could
be detected in raw lamb meat using the GFAP kit, while 1.0% (g/g) was detected by the NSE
kit. The detection limits of the GFAP and NSE methods for cooked samples (80 °C for 40 min)
were 0.2% (g/g) bovine brain in pork and 0.1% (g/g) bovine spinal tissue in pork, respectively.
They noted that the GFAP assay was easier to use and to interpret the data than the NSE assay.
In a similar study by Agazzi et al. [138], the sensitivity of the NSE test kit was reported as being
0.5% (g/g) CNS tissue in raw and medium-heated (80 °C for 20 min) meat samples, rising to
2.0% (g/g) in strongly heated (120 °C for 20 min) meat materials. Another study [146] also found
that the NSE immunoreactivity in samples of pure brain and brain muscle dropped signifi‐
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cantly with time at 100 °C, almost disappearing after a 2 h heat treatment. The properties of
these commercial kits are summarized in Table 3.
Company ScheBo Biotech AG R-Biopharm ELISA Technologies Neogen
Commercial kit name Brainostic Test (GFAP-
ELISA) 
RIDASCREEN Risk 
Material  
RIDASCREEN Risk 
Material 10/5 
MELISA-TEK Ruminant 
Kit 
Reveal for 
Ruminant in Feed  
Reveal for 
Ruminant in 
MBM 
Detection method  sELISA* sELISA sELISA sELISA LFA* LFA 
LOD (%) 0.1 0.2 0.1 0.5 1 2 
Target products  Raw, processed (heated) 
meat and on 
contaminated surfaces 
Processed (heated) meat 
and sausages 
Raw meat, meat 
products and on 
contaminated surfaces 
MBM Ruminant Ruminant 
Sample preparation Homogenization, 
extraction, swabs, 
dilution 
Homogenization, 
extraction, 
centrifugation, dilution 
Place the sampling swab 
into the sample dilution 
buffer 
Extraction Extraction Extraction 
Species selectivity Unknown Cattle, veal, sheep, goat, 
horse, poultry and pig 
Cattle, veal, sheep, goat, 
horse, poultry and pig 
Beef, sheep and water 
buffalo 
N/A* N/A 
Tissue specificity Unknown No No Muscle Muscle Muscle 
Minimum sample 
amount  
50 mg 2 g  50 mg 5 g 10 g  10 g 
Antigen#  GFAP* GFAP  GFAP  Troponin-I Troponin-I Troponin-I 
Test implementation 45 min 1 h 15 min 1 h 10 min 15 min 
Tests possible per kit  42 (each in duplicate) 96 (including standards) 96 (including standards) 16 (each in triplicate) 25 25 
Kit store temperature 4–8 °C 2–8 °C 2–8 °C 4–8°C 18–30 °C 18 − 30˚C 
Standards provided  0.1, 0.2, 0.4 and 1.0% 0, 0.2, 1.0 and 2.0%  0, 0.1, 0.2 and 0.4%  No No No 
*sELISA: sandwich ELISA; GFAP: glial fibrillary acidic protein; LFA: immunochromatographic lateral flow assay; N/A: not available 
Table 3. Commercial immunoassay kits for the detection of prohibited CNS and ruminant tissue contaminants in meat
and feed products
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5.2.3. Myelin proteolipid protein
In the CNS, myelin proteolipid protein (MPP, MW: 30 kDa) makes up approximately 50% of
the myelin proteins [161]. This protein can be readily extracted from brain white matter using
organic solvents [162]. Although MPP is the most abundant myelin protein in the CNS, mRNA
for PLP is also expressed in the PNS and small amounts of MPP are synthesized [162]. This
protein has also been used as a marker for the detection of CNS tissue in meat products [163].
The detection limit for CNS in raw meat can be as low as 0.025% using Western blot [164], and
0.01% bovine brain in raw minced beef using dot blot [165]. However, the antibody used in
these studies was not species-specific and was unable to differentiate between mammalian
species. Another problem is that MPP is not thermostable; the reaction signal decreased
significantly when the heating time was increased to 95 °C. MPP was not detectable after 3 h
of heat treatment at this temperature using dot blot [164].
5.2.4. Myelin Basic Protein (MBP)
MBP is located in CNS on the cytoplasmic face of myelin membranes in the white matter
corresponding to the major dense line. MBP makes up about 30% of the total protein in the
mammalian CNS myelin. It is the only structural protein found so far that is essential for the
formation of CNS myelin [166]. As a water-soluble protein, MBP can be extracted with either
acid or salt solutions [162]. There are four isoforms of MBP, each with a different molecular
weight: 21 kDa, 18.5 kDa, 17 kDa and 14 kDa [162]. Different animal species have different
isoforms. In particular, 18.5-kDa MBP, the major isoform protein in the CNS, is highly unfolded
with essentially no tertiary structure in solution and the amino acid sequence of this major
basic protein is similar in a number of animal species [162]. The sequence identity of the 18.5-
kDa MBP in bovines and pigs is 93% homologous [167]. It has been reported that bovine 18.5-
kDa MBP is not only very stable in solution at neutral pH (pH 7.2), but also highly thermostable
[168]. Its immunoreactivity has been shown to remain clearly detectable even after severe heat
treatment at 133 °C for 30 min [168].
MBP has been used as a marker for the detection of CNS contamination using immunoassays
in several studies.[136, 143, 145, 147, 151] Levels as low as 1% (g/g) of bovine brain have been
detected in a heated luncheon meat-type product (115 °C for 1 h) using a pAb in immunohis‐
tochemistry[151] and a mAb in immunoblotting.[147] In another study,[136] a detection limit
of 10% was recorded for CNS tissue using a mAb in indirect competitive ELISA. Using an
improved MBP extraction method,[143] compared with the detection limit reported using the
same antibody and the same ELISA method,[136] the detection limit for brain tissue could be
enhanced from 10 to 0.05% (~200 times). This improved extraction method will provide a useful
analytical basis for the subsequent development of a specific immunoassay for the detection
of bovine CNT in processed meat and feed products.
5.3. Detection methods for the control of prion diseases in feed products
To safeguard livestock, a number of non-immunochemical and immunochemical detection
methods have been developed to detect the presence of banned animal materials in feeds. A
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high-performance liquid chromatography method has been developed that utilizes dipeptide
carnosine and related dipeptides as the markers,[169] and several other studies have used near-
infrared reflectance spectroscopy (NIRS) to predict the amino acid content in animal feeds.
[170-172] PCR has also been used for the detection of animal tissue in feeds. For example, Gao
et al.[173] amplified a highly conserved eukaryotic DNA region of the 18S ribosomal gene using
multiplex PCR (MPCR) and were able to detect levels as low as 0.02% bovine MBM in
feedstuffs. Bellagamba et al.[174] detected 0.25% ruminant or pig adulterants in fish meal by
MPCR.
A number of immunoassays have been developed to detect prohibited ruminant animal
materials in feed. In our laboratory, a panel of species-specific mAbs have been produced for
the detection of animal tissues in both food and feed products. [175-177] A skeletal muscle
protein, troponin I (sTnI, 24 kDa), was first identified as a thermal-stable species marker
protein; sTnI maintains its solubility and antigenicity even after undergoing severe heat
treatment (126 °C for 120 min).[177] Given its even distribution in skeletal muscles, sTnI
appears to be an ideal marker, allowing antibodies to be developed for the detection of animal
tissues in severely heat-treated samples such as MBM. sTnI-specific mAbs have demonstrated
their usefulness in an indirect non-competitive ELISA for the detection of rendered muscle
tissues in animal feedstuffs, with detection limits of the mammalian and ruminant assays being
between 0.3 and 2%.[175] In 2004, a sandwich ELISA was reported for the detection of ruminant
proteins in feedstuffs.[176] This assay used a capture mAb specific to bovine and ovine sTnI
and a biotin-conjugated detection mAb that reacts to all animal sTnI. The optimized assay
achieved detection limits for bovine and ovine sTnI as low as 5.0 and 4.0 ng/ml, respectively.
[176] Based on the detection of sTnI, several commercial immunoassay kits are now available
for the enforcement of ruminant feed ban regulations (Table 3).
6. Conclusions
In order to maximize the economic profit from animal food production, humans made
livestock animal’s cannibals in the 1970s. Only a few years later, this backfired spectacularly,
resulting in the rapid spread of infectious PrPSc through both the feed and food chains. These
practices created a huge man-made disaster, mad cow disease, which went on to enter the
human food chain through poor animal slaughtering and meat processing practices. The
devastating impact of BSE on cattle has been called “a punishment from God” from which the
global beef industry is only now beginning to recover. Although the negative impacts of the
human version of mad cow disease, vCJD, are less significant, they continue to receive a great
deal of publicity and the risk of recurrence of the disaster cannot be ignored. Most countries
and areas have now enacted legislation to prohibit the use of SRM in the food and feed chain,
and the goal of everyone concerned is to eventually eliminate the threat of BSE completely.
Currently, through the strict implementation of feed bans and the enforcement of the regula‐
tions, both types of foodborne prion diseases appear to be under control. However, the
prevention of prion diseases is not simply a matter of food or feed safety, but is also a significant
factor affecting a number of political and economic issues. Effective detection methods for
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ruminant SRM in rendered feedstuffs are still lacking, as currently none of the available assays
can effectively differentiate ruminant CNS tissue from that of non-ruminant animal species,
or detect bovine CNS tissue in excessively processed (e.g., 133 °C for 20 min) meat and feed
products. It is therefore vital to continue to conduct scientific research in this area if we are to
gain a better understanding of these destructive prion diseases and develop more effective
surveillance techniques for this disease in both humans and animals. We must take to heart
this solemn lesson if we are to avoid another such punishment from God.
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